SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

The FDA's issuance of a Complete Response Letter (CRL) for Regenxbio's RGX-121 gene therapy for Hunter syndrome is driving intense conversation, with the community expressing significant concerns about the trial design, financial implications, and potential dilution amidst broader scrutiny of gene therapy development.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

FISV is trending intensely ahead of its earnings, with the community sharply divided between those anticipating a strong rebound fueled by perceived undervaluation, recent institutional accumulation, and new leadership's strategic moves, and those fearing another significant drop due to past disappointments, heavy put option activity, and ongoing fintech sector concerns.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl (KD) is in focus following the abrupt departure of its CFO and general counsel amidst an accounting review and delayed regulatory filings, triggering a severe sell-off. The community is debating whether the IT infrastructure provider's over 50% stock drop is an extreme overreaction and a buying opportunity, or a justified response to serious governance concerns.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group (CRDO) is surging after pre-announcing preliminary Q3 revenue significantly above prior guidance and consensus, coupled with a robust outlook for sequential growth into fiscal year 2027. The community is vigorously discussing this strong performance, highlighting its crucial role in the ongoing AI data center buildout and the massive capital expenditure increases from hyperscalers, expecting continued upward momentum.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is experiencing significant volatility following its mixed Q4 earnings, which showed an EPS beat but a revenue miss and conservative 2026 guidance prioritizing prudent risk management. While the market is punishing PGY, many in the community view the dramatic sell-off as an extreme overreaction given the company's profitability, strong fundamentals, and historically low valuation compared to peers in the fintech and AI sectors.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

Amkor Technology is trending following its robust Q4 earnings beat, though a mixed Q1 outlook is fueling debate among investors between short-term caution and long-term optimism regarding its pivotal role in advanced AI and data center packaging, bolstered by strategic investments and CHIPS Act funding.

Silvercorp Metals, Inc. engages in the acquisition, exploration, development, and mining of mineral properties and Environmental, Social and Governance practices. It operates through Mining and Administrative segments. The Mining segment includes Henan Luoning, Guangdong, and others. Its products include Silverbearing lead and Zinc Concentrates.The Administrative segment focuses on Vancouver and Beijing. The company was founded by Rui Feng on October 31, 1991 and is headquartered in Vancouver, Canada.

Silvercorp Metals Inc

Silvercorp Metals Inc.

Silvercorp Metals is trending due to a blowout quarterly earnings report that exceeded estimates, with the community actively discussing its perceived undervaluation and anticipating a significant price surge, bolstered by strong precious metals market conditions.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending amid anticipation for its upcoming earnings and significant market speculation regarding the uncertain fate of a House-passed bill to extend ACA subsidies; the community remains sharply divided, with some foreseeing a major re-rating due to policy tailwinds and execution, while others highlight financial challenges and broader sector headwinds.

Upwork, Inc. is an online marketplace which engages in the provision of businesses to find, hire, and pay freelancers for short-term and longer-term projects. Its marketplace offerings include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The company was founded by Odysseas Tsatalos and Efstratios Karamanlakis in December 2013 and is headquartered in Palo Alto, CA.

Upwork Inc

Upwork is trending lower after its latest earnings report, with disappointing Q1 guidance overshadowing beats on Q4 figures and positive long-term projections. The community is actively debating whether the significant price drop is an overreaction or signals deeper concerns about AI's impact on the gig economy and the company's future growth trajectory.

Synopsys, Inc. engages in the provision of electronic design automation (EDA) software that engineers use to design and test integrated circuits (ICs). It also offers semiconductor intellectual property (IP) products. It operates through the Design Automation and Design IP segments. The Design Automation segment includes silicon design, verification of products and services, and Ansys products, and system integration of products and services. The Design IP segment refers to interface, foundation, security, and embedded processor IP, IP subsystems, and IP implementation services that serve companies primarily in the semiconductor and electronics industries. The company was founded by Aart J. de Geus, Bill Krieger, Dave Gregory, and Rick Rudell in December 1986 and is headquartered in Sunnyvale, CA.

Synopsys, Inc.

Synopsys Inc

Synopsys is trending after Nvidia's $2 billion strategic investment and expanded partnership, which the community views as a significant validation of its indispensable role in AI-driven chip design and engineering. This collaboration solidifies Synopsys' position as a critical enabler in the booming semiconductor industry.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Tenon Medical, Inc. surged more than 280% on Tuesday, marking their best day ever, with the nano-cap medical device firm's retail following&nbsp;on Stocktwits surging the most among healthcare stocks after a key regulatory approval.During after-hours trading on Monday, Tenon said that the U.S. Food and Drug Administration had cleared its Catamaran SI Joint Fusion System for expanded use in augmenting thoracolumbar fusion."With this approval, the Catamaran is now indicated to treat the SI [sacroiliac] joint as either a stand-alone treatment or to augment a spinal fusion," the company said in a statement.Tenon's Catamaran system is designed as a minimally invasive solution for stabilizing the joint where the lower spine and pelvic bone meet. It uses a single titanium implant to secure the joint by passing through key bone structures.&nbsp;On Stocktwits, Tenon gained 25% more followers from a day ago, as sentiment turned even more 'extremely bullish' while message volume soared by 813%.One user said if the stock breaks the $5 level again, it "will go to $7+ fast. Shorts will have to cover."<stembedurl>https://stocktwits.com/BullsEye2000/message/609170603</stembedurl>However, Tenon shares fell more than 5% in Tuesday's extended trading after the company announced a $1.5 million registered direct offering to a healthcare-focused institutional investor.&nbsp;Under the agreement, Tenon will issue 733,500 shares at $2 each and an equal number of warrants exercisable at the same price.&nbsp;The company expects to close the offering on Wednesday, and the proceeds will be used for working capital and general corporate purposes.However, several optimistic retail watchers were still not rankled. One user said, "Everyone's panicking over the offering, but it was a direct offering so it got them secured cash to move forward without diluting the base rapidly."<stembedurl>https://stocktwits.com/FLCaptain/message/609231053</stembedurl>Tenon's stock has gained a whopping 93% so far this year. The sole analyst covering it on Wall Street rates it a 'strong buy,' according to Koyfin.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Tenon Medical Stock Rockets Nearly 4x, Leads Retail Follower Surge In Healthcare: What's Driving The Hype?

The medical device company said that the FDA had cleared its Catamaran SI Joint Fusion System for expanded use in augmenting thoracolumbar fusion.

Equity

Shares of surgical solutions firm Tenon Medical, Inc (TNON) shot up over 145% on Friday after the company announced the pricing of its public offering of shares and warrants in order to meet a Nasdaq minimum float requirement.The firm had earlier received a letter from Nasdaq stating that it did not meet the “minimum 500,000 publicly held shares requirement.”&nbsp;The compliance issue followed Tenon Medical common stock’s 1-for-8 reverse split which reduced the firm’s outstanding common stock from a little over 4.08 million shares to 510,221 shares outstanding on a post-reverse split basis. Only 490,364 of such shares qualified as publicly held shares for purposes of the minimum float requirement, the firm said in an SEC filing.Nasdaq had provided time till October 24, 2024 for the firm to come up with a plan to regain the compliance. Tenon, however, stated that it expects to regain compliance with the minimum float requirement in September itself.On Friday, the company announced the pricing of its "reasonable best efforts" public offering with a single health-care focused institutional investor for the purchase and sale of up to 1,222,850 shares of common stock and warrants to purchase an equal number of shares at a combined offering price of $3.68 per share.Tenon expects to receive aggregate gross proceeds of approximately $4.5 million, assuming no exercise of the warrants. The firm said that the warrants will have an exercise price of $3.55 per share and will be exercisable immediately. They will expire five years from the issuance date, Tenon said.The offering is expected to close on Sept. 16, 2024, with Tenon intending to use the net proceeds for commercial activity, working capital and general corporate purposes.In early September, the firm entered into a securities purchase agreement with certain investors to offer a total of 86,454 Series B preferred stock and warrants to purchase 16,214 shares of common stock at an exercise price equal to $4.2756 per share for an aggregate offering price of $550,000.Tenon Medical’s shares have gained more than 87% over the last month, with the firm attracting investor eyeballs in the wake of the compliance developments.&nbsp;As a result, Stocktwits message volume shot up a whopping 64,900% during the same period as investors continued to discuss the fate of the stock.Some investors, however, are advising to maintain caution.<stembedurl>https://stocktwits.com/Spacerobot/message/585993209</stembedurl>Also See: <a href="https://stocktwits.com/news/markets/equity/united-airlines-to-offer-free-inflight-wifi-using-spacexs-starlink/c7zC6s5R5e">United Airlines To Offer Free Inflight Wi-Fi From SpaceX’s Starlink: Retail Sentiment Gets A Boost</a>

Nasdaq had provided time till October 24, 2024 for Tenon Medical to come up with a plan to regain the compliance.

Tenon Stock Skyrockets 145% After Public Offering To Meet Nasdaq Rules: Retail Chatter Goes Through The Roof

The firm had earlier received a letter from Nasdaq stating that it did not meet the “minimum 500,000 publicly held shares requirement.”

Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company was founded by Richard Ferrari and Richard Ginn on June 19, 2012 and is headquartered in Los Gatos, CA.

Tenon Medical Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

Current Price	$0.82
Prev Close	$0.6712
Open	$0.8012
Dividend Yield	0.00%
50-Day Moving Average	$1.00
Beta	0.85
Avg. Volume	74,055.70
PE Ratio	-0.24

52-Week High	$5.85
52-Week Low	$0.641
Market Capitalization	$7.45M
EPS (Annual)	-$11.26
Price to Book	3.35
Revenue Per Employee	$121,370.37
Enterprise Value/EBITDA	N/A

TNON
Tenon Medical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TNON News

TNONTenon Medical Inc